Molecules/TRASTUZUMAB BOTIDOTIN

TRASTUZUMAB BOTIDOTIN

Molecular Identity

Antibody drug conjugatePhase 2

Mechanism of action: Receptor tyrosine-protein kinase erbB-2 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

A 166A-166A166TRASTUZUMAB BOTIDOTINTRASTUZUMAB BOTIDOTINATRASTUZUMAB BOTIDOTINE

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to TRASTUZUMAB BOTIDOTIN

Loading drug network...